论文部分内容阅读
报告了同种异体肾移植７２７例，７４６例次。术后发生超急性排斥反应１２例次，急性排斥反应２３８例次，慢性排斥反应６６例次。人肾总存活率：１年者为９４．１％和８６．１％，３年者为８８．６％和７７．９％，５年者为８１．５％和７０．５％，最长者存活１５年４个月．７４６例次的临床研究表明：（１）高质量的供肾、快速取肾和熟练的植肾手术是保证肾移植成功的重要条件之一。（２）应坚持ＡＢＯ血型，淋巴细胞毒性试验及ＰＲＡ配型工作。（３）合理应用免疫抑制剂．将激素减到最低量及环孢素血浓度的监测甚为重要。（４）感染是肾移植失败的重要原因，要充分做好预防感染的工作。（５）加强对肾移植患者随访，指导康复期的治疗，随时调节免疫抑制剂，这时患者能否长期存活有重要意义。
Allograft kidney transplantation was reported in 727 cases, 746 cases. There were 12 cases of hyperacute rejection after operation, 238 cases of acute rejection and 66 cases of chronic rejection. The overall survival rate of human kidney was 94.1% and 86.1% for 1 year, 88.6% and 77.9% for 3 years, 81.5% and 70.5% for 5 years, and the longest Survival 15 years and 4 months. 746 cases of clinical studies have shown that: (1) high-quality donor kidney, rapid renal access and skilled kidney transplant surgery is one of the important conditions to ensure the success of renal transplantation. (2) should adhere to the ABO blood type, lymphocyte cytotoxicity test and PRA matching work. (3) rational use of immunosuppressive agents. Monitoring hormones to a minimum and cyclosporine concentrations is important. (4) infection is an important reason for the failure of kidney transplantation, to fully do a good job in preventing infection. (5) to strengthen the follow-up of renal transplant patients, to guide the treatment of convalescent, immunosuppressive agents at any time, then patients with long-term survival is important.